NCT00755560

Treatment of Asymptomatic Toxocariasis With Albendazole in Children

Treatment of Asymptomatic Toxocariasis With Albendazole in Children. A Prospective, Randomized, Placebo-controlled Clinical Trial

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Hospital de Niños R. Gutierrez de Buenos Aires · Academic / Other
• Sex: All
• Age: 2 Years – 15 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate effectiveness of albendazole in the treatment of the asymptomatic infection with the parasite Toxocara in children. Treatment response is defined as a reduction in the number of eosinophils in blood. The study drug will be compared to placebo and randomly assigned in a double blind manner. Follow up will be prospective. 50 children (25 per group) will be enrolled in the study.

Conditions

• Toxocariasis

Interventions

Type	Name	Description
DRUG	Albendazole	Albendazole 10 - 15 mg/kg/day BID for 15 days
DRUG	Placebo	Placebo BID for 15 days

Timeline

• Start date: 2008-09-01
• Primary completion: 2015-07-01
• Completion: 2025-07-01
• First posted: 2008-09-19
• Last updated: 2023-03-02

Locations

1 site across 1 country: Argentina